These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 24565845)

  • 1. The progression of comorbidity in IL-18 transgenic chronic obstructive pulmonary disease mice model.
    Takenaka S; Kawayama T; Imaoka H; Sakazaki Y; Oda H; Kaku Y; Matsuoka M; Okamoto M; Kato S; Yamada K; Hoshino T
    Biochem Biophys Res Commun; 2014 Mar; 445(3):597-601. PubMed ID: 24565845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary inflammation and emphysema: role of the cytokines IL-18 and IL-13.
    Hoshino T; Kato S; Oka N; Imaoka H; Kinoshita T; Takei S; Kitasato Y; Kawayama T; Imaizumi T; Yamada K; Young HA; Aizawa H
    Am J Respir Crit Care Med; 2007 Jul; 176(1):49-62. PubMed ID: 17400729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High levels of serum IL-18 promote cartilage loss through suppression of aggrecan synthesis.
    Inoue H; Hiraoka K; Hoshino T; Okamoto M; Iwanaga T; Zenmyo M; Shoda T; Aizawa H; Nagata K
    Bone; 2008 Jun; 42(6):1102-10. PubMed ID: 18374640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of chitinase 3-like 1/YKL-40 in lung-specific IL-18-transgenic mice, smokers and COPD.
    Sakazaki Y; Hoshino T; Takei S; Sawada M; Oda H; Takenaka S; Imaoka H; Matsunaga K; Ota T; Abe Y; Miki I; Fujimoto K; Kawayama T; Kato S; Aizawa H
    PLoS One; 2011; 6(9):e24177. PubMed ID: 21915293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of interleukin-6 in pulmonary and systemic manifestations in a murine model of chronic obstructive pulmonary disease.
    Pauwels NS; Bracke KR; Maes T; Pilette C; Joos GF; Brusselle GG
    Exp Lung Res; 2010 Oct; 36(8):469-83. PubMed ID: 20939756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-18 production and pulmonary function in COPD.
    Imaoka H; Hoshino T; Takei S; Kinoshita T; Okamoto M; Kawayama T; Kato S; Iwasaki H; Watanabe K; Aizawa H
    Eur Respir J; 2008 Feb; 31(2):287-97. PubMed ID: 17989120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of IL-1α and the Nlrp3/caspase-1/IL-1β axis in cigarette smoke-induced pulmonary inflammation and COPD.
    Pauwels NS; Bracke KR; Dupont LL; Van Pottelberge GR; Provoost S; Vanden Berghe T; Vandenabeele P; Lambrecht BN; Joos GF; Brusselle GG
    Eur Respir J; 2011 Nov; 38(5):1019-28. PubMed ID: 21622588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelial cell adhesion molecule CD146: implications for its role in the pathogenesis of COPD.
    Kratzer A; Chu HW; Salys J; Moumen Z; Leberl M; Bowler R; Cool C; Zamora M; Taraseviciene-Stewart L
    J Pathol; 2013 Aug; 230(4):388-98. PubMed ID: 23649916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of endothelial apoptosis underlying chronic obstructive pulmonary disease-like phenotype in adiponectin-null mice: implications for therapy.
    Nakanishi K; Takeda Y; Tetsumoto S; Iwasaki T; Tsujino K; Kuhara H; Jin Y; Nagatomo I; Kida H; Goya S; Kijima T; Maeda N; Funahashi T; Shimomura I; Tachibana I; Kawase I
    Am J Respir Crit Care Med; 2011 May; 183(9):1164-75. PubMed ID: 21239691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone malformations in interleukin-18 transgenic mice.
    Kawase Y; Hoshino T; Yokota K; Kuzuhara A; Nakamura M; Maeda Y; Nishiwaki E; Zenmyo M; Hiraoka K; Aizawa H; Yoshino K
    J Bone Miner Res; 2003 Jun; 18(6):975-83. PubMed ID: 12817749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic bone loss, impaired osteogenic activity and type I muscle fiber atrophy in mice with elastase-induced pulmonary emphysema: Establishment of a COPD-related osteoporosis mouse model.
    Tsukamoto M; Mori T; Wang KY; Okada Y; Fukuda H; Naito K; Yamanaka Y; Sabanai K; Nakamura E; Yatera K; Sakai A
    Bone; 2019 Mar; 120():114-124. PubMed ID: 30342225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Auto-measure emphysematous parameters and pathophysiological gene expression profiles in experimental mouse models of acute and chronic obstructive pulmonary diseases.
    Nakashima R; Kamei S; Nohara H; Fujikawa H; Maruta K; Kawakami T; Eto Y; Takahashi N; Suico MA; Takeo T; Nakagata N; Kai H; Shuto T
    J Pharmacol Sci; 2019 Jun; 140(2):113-119. PubMed ID: 31248767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comorbidities in COPD].
    de Miguel Díez J; García TG; Maestu LP
    Arch Bronconeumol; 2010 Dec; 46 Suppl 11():20-5. PubMed ID: 21316557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transgenic and gene-targeted mice as models for chronic obstructive pulmonary disease.
    Shapiro SD
    Eur Respir J; 2007 Feb; 29(2):375-8. PubMed ID: 17264324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-13-driven pulmonary emphysema leads to skeletal muscle dysfunction attenuated by endurance exercise.
    Balnis J; Korponay TC; Vincent CE; Singer DV; Adam AP; Lacomis D; Lee CG; Elias JA; Singer HA; Jaitovich A
    J Appl Physiol (1985); 2020 Jan; 128(1):134-148. PubMed ID: 31774358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TNF alpha receptor genotype influences smoking-induced muscle-fibre-type shift and atrophy in mice.
    De Paepe B; Brusselle GG; Maes T; Creus KK; D'hose S; D'Haese N; Bracke KR; D'hulst AI; Joos GF; De Bleecker JL
    Acta Neuropathol; 2008 Jun; 115(6):675-81. PubMed ID: 18309502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-1beta causes pulmonary inflammation, emphysema, and airway remodeling in the adult murine lung.
    Lappalainen U; Whitsett JA; Wert SE; Tichelaar JW; Bry K
    Am J Respir Cell Mol Biol; 2005 Apr; 32(4):311-8. PubMed ID: 15668323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary hypertension is ameliorated in mice deficient in thrombin-activatable fibrinolysis inhibitor.
    Qin L; D'Alessandro-Gabazza CN; Aoki S; Gil-Bernabe P; Yano Y; Takagi T; Boveda-Ruiz D; Ramirez Marmol AY; San Martin Montenegro VT; Toda M; Miyake Y; Taguchi O; Takei Y; Morser J; Gabazza EC
    J Thromb Haemost; 2010 Apr; 8(4):808-16. PubMed ID: 20088932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. State of the art. Mechanistic heterogeneity in chronic obstructive pulmonary disease: insights from transgenic mice.
    Elias JA; Kang MJ; Crothers K; Homer R; Lee CG
    Proc Am Thorac Soc; 2006 Aug; 3(6):494-8. PubMed ID: 16921126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic obstructive pulmonary disease is associated with the -1055 IL-13 promoter polymorphism.
    van der Pouw Kraan TC; Küçükaycan M; Bakker AM; Baggen JM; van der Zee JS; Dentener MA; Wouters EF; Verweij CL
    Genes Immun; 2002 Nov; 3(7):436-9. PubMed ID: 12424628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.